Intravenous versus subcutaneous delivery of biotherapeutics in IBD: an expert’s and patient’s perspective

Several biologic treatments are available in addition to intravenous also in subcutaneous form for treatment of chronic diseases. Benefits of the subcutaneous application of drugs include self-administration by the patient, shorter time of application process with less infusion related adverse event...

Descripción completa

Detalles Bibliográficos
Autores principales: Jonaitis, Laimas, Marković, Srdjan, Farkas, Klaudia, Gheorghe, Liana, Krznarić, Željko, Salupere, Riina, Mokricka, Viktorija, Spassova, Zoya, Gatev, Dimo, Grosu, Isabella, Lijović, Anton, Mitrović, Olga, Saje, Mateja, Schafer, Eszter, Uršič, Viktor, Roblek, Tina, Drobne, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Meeting Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8654488/
https://www.ncbi.nlm.nih.gov/pubmed/34879868
http://dx.doi.org/10.1186/s12919-021-00230-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8654488/
https://www.ncbi.nlm.nih.gov/pubmed/34879868
http://dx.doi.org/10.1186/s12919-021-00230-7

Ejemplares similares